DIA 48th Annual Meeting
Click here to go to the previous page
From Adverse Events to Adverse Drug Reactions: Statistical Issues in Safety Labeling
Track : Track 15: Statistical Science and Quantitative Thinking
Program Code: 344
Date: Wednesday, June 27, 2012
Time: 10:00 AM to 11:30 AM  EST
CHAIR :
 Andreas Brueckner, Bayer, Germany
PRESENTER (S):
 Conny Berlin, Novartis Pharma AG, Switzerland
 LaRee Tracy, FDA, United States
Ed Whalen, Pfizer Inc, United States
Description
This session will highlight statistical issues that arise during this review process, discussing approaches for screening, identification, quantification and presentation of individual adverse drug reactions for drug safety labeling.

Learning Objectives:
Recognize the current quantitative approaches in labeling adverse drug reactions information
Summarize relevant statistical issues of safety labeling
Discuss the impact of novel approaches adverse drug reaction labeling.